Biggest News Aggregation in the World

Relapsed Refractory Aml News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relapsed Refractory Aml. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relapsed Refractory Aml Today - Breaking & Trending Today

$Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML - Vimarsana News$

Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML

Published: July 12, 2023

Expert Amir Fathi, MD, reviews recent clinical data with ziftomenib in patients with relapsed/refractory acute myeloid leukemia.

Source: onclive.com